Sciences de la Santé
References:
1- United Nations Office on Drugs and Crime. World Drug
Report 2018. United Nations publication, Sales No. E.18.XI.9.
Available from: https://www.unodc.org/wdr2018.
2- Strain E.Opioid use disorder: Epidemiology, pharmacology,
clinical manifestations, course, screening, assessment, and
diagnosis. Uptodate 2018.
3- Schmitt S. Osteomyelitis. Infectious Disease Clinics of
North America. 2017;31(2):325-338.
4- Berbari E, Kanj S, Kowalski T, Darouiche R, Widmer A,
Schmitt S et al. 2015 Infectious Diseases Society of Ameri-
ca (IDSA) Clinical Practice Guidelines for the Diagnosis and
Treatment of Native Vertebral Osteomyelitis in Adults. Clini-
cal Infectious Diseases. 2015;61(6):e26-e46.
5- Sande MA, Lee BL, Mills J, et al. Endocarditis in intrave-
nous drug users. In: Infective Endocarditis, Kaye D (Ed), Ra-
ven Press, New York City 1992. p.345.
6- Quagliarello B, Cespedes C, Miller M, Toro A, Vavagiakis
P, Klein R et al. Strains of Staphylococcus aureus Obtained
from Drug-Use Networks Are Closely Linked. Clinical Infec-
tious Diseases. 2002;35(6):671-677.
7- Gordon RJ, Lowy FD. Bacterial Infections in Drug Users. N
Engl J Med 2005;353:1945-54.
12
Été 2018
8- Ryznar E, O’Gara PT, Lilly LS. Valvular Heart Disease. In:
Pathophysiology of heart disease (Lilly), 6th edition, 2016.
p.212.
9- Habib G, Lancellotti P, Antunes M, Bongiorni M, Casalta
J, Del Zotti F et al. 2015 ESC Guidelines for the manage-
ment of infective endocarditis. European Heart Journal.
2015;36(44):3075-3128.
10- Martı´n-Da´vila et al. Analysis of mortality and risk factors
associated with native valve endocarditis in drug users: The
importance of vegetation size. American Heart Journal.2015
; 150(5) :1099-1106.
11- Joint United Nations Programme on HIV/AIDS. The GAP
report. UNAIDS Information Production Unit. September
2014. Available from: http://www.unaids.org/sites/default/
files/media_asset/UNAIDS_Gap_report_en.pdf.
12- Tortu S, McMahon JM, Pouget ER, Hamid R. Sharing of
noninjection drug-use implements as a risk factor for hepa-
titis C. Subst Use Misuse. 2004;39(2):211.
13- Edlin BR, Carden MR, FerrandoSJ. Managing Hepatitis C
in Users of Illicit Drugs. Curr Hepat Rep. 2007 ; 6(2): 60–67.
14- Li H-C, Lo S-Y. Hepatitis C virus: Virology, diagnosis and
treatment. World J Hepatol 2015 June 8; 7(10): 1377-1389.